In fact, it was found to be strongly expressed in tumor cells of several adenocarcinomas, whereas normal matched epithelia contain very low levels of this chaperone [64,65,66]; conversely, recent data show a more complex scenario with a lower expression of TRAP1 in lung cancer and cisplatin-resistant ovarian cancer cells (see previous section and [40]). This evidence concerns the gene TRAP1 and neoplasm.